Biologic drugs, made mainly from antibodies, have transformed the approach to treating chronic inflammatory diseases such as asthma and rheumatoid arthritis. We explore their mechanisms and potential.

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with incre ...

You just finished a satisfying summer hike or wrapped up a weekend of yard work when you spot a tick clinging to your clothes ...

Women with immune-mediated inflammatory diseases (IMIDs) face higher CVD-related mortality rates than do men, according to recently published research.

A recent study published in Engineering has shed light on a novel combination therapy for rheumatoid arthritis (RA) that significantly reduces bone ...

Oklahoma Proton Center and its partner, Oklahoma Cancer Center, are proud to be one of just a handful of locations in the ...

Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist ...

Patients with inflammatory bowel disease may be twice as likely to develop rheumatoid arthritis than those without IBD.

This difference was not statistically significant, but response rates in the high-volume group were significantly higher than ...

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes. This study sought to explore the syndrome's role in a more precisely ...

Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...

Harliku is the only FDA-approved drug for alkaptonuria, a rare condition characterized by skin discoloration, arthritis and ...